|
|
|
|
|
|
|
|
|
|
|
|
|
EXHIBIT E-14
BALANCE SHEET AND CONDENSED INCOME
STATEMENT
For
SIX-MONTH PLERIOD ENDING JUNE 30, 2000
|
NeuroGenesis, Inc | ||
| YTD Actual | % | |
|
INCOME FROM SALES |
|
|
|
beCALM'd Sales |
156,261 |
59.6 |
|
NeuRecover-DA Sales |
38,173 |
14.5 |
|
NeuRecover-SA Sales |
10,648 |
4 |
|
Neuro Slim |
7,528 |
2.8 |
|
Ultratrend |
1,577 |
0.6 |
|
Inca Gold (60 Capsules) |
1,761 |
0.6 |
|
Booklets - Nautral Path ... |
0 |
** |
|
Manuals |
0 |
** |
|
Books & Manuals |
0 |
** |
|
S&H Charged to Customer |
0 |
** |
|
Royalty Income |
1,717 |
0.6 |
|
Misc. Income |
45,385 |
17.3 |
|
Sales Returns |
(740) |
0.2 |
|
|
|
|
|
Total Sales |
262,311 |
100 |
|
|
|
|
|
COST OF GOODS SOLD |
|
|
|
beCALMtd |
34,197 |
13 |
|
NeuRecover-DA |
8,631 |
3.2 |
|
NeuRecover-SA |
2,351 |
0.9 |
|
NeuroSlim - 1 80 Cap |
2,396 |
0.9 |
|
Utratrend |
445 |
0.1 |
|
Inca Gold 60 Cap |
238 |
** |
|
Books and Manuals |
(153) |
** |
|
Misc. Cost Of Goods Sold |
1,432 |
0.5 |
|
Total Manufacturing Costs |
49,536 |
18.9 |
|
Inventory Loss <Gain> |
1,718 |
0.6 |
|
Total Costs Of Goods Sold |
51,254 |
19.5 |
|
|
======= |
|
|
GROSS MARGIN |
211,057 |
80.5 |
| G & A EXPENSES | ||
|
Directors' Fees |
500 |
0.1 |
|
Travel & Entertainment |
0 |
** |
|
Public Relations |
3 |
** |
|
Financing Costs |
0 |
** |
|
Patent Expense |
1,820 |
0.6 |
|
Bank Charges |
1,575 |
0.6 |
|
Amort. Expense - Patents |
274 |
0.1 |
|
Stock Transfer Exp. |
77 |
** |
|
Salaries & C.O.E. - G & A |
0 |
** |
|
Facilities Expenses |
|
|
|
Office Rental |
10,404 |
3.9 |
|
Utilities |
0 |
** |
|
Local Telephone |
461 |
0.1 |
|
L.D. Telephone |
1,541 |
0.5 |
|
Bookkeeping & Acctg Expense |
0 |
** |
|
Travel & Entertainment |
447 |
0.1 |
|
Office Supplies |
303 |
0.1 |
|
NeuroGenesis, Inc | ||
|
|
YTD Actual |
% |
|
Copier Expense |
1,406 |
0.5 |
|
Fax Expense |
19 |
** |
|
Depr Exp Computers |
1,043 |
0.4 |
|
Depr. Exp. - Furn. & Fixtures |
209 |
** |
|
Postage |
328 |
0.1 |
|
Computer Supplies |
1,742 |
0.6 |
|
Computer Software |
0 |
** |
|
Audit |
6,400 |
2.4 |
|
Legal |
26,607 |
10.1 |
|
Insurance Expense |
1,535 |
0.5 |
|
organizational Expense |
0 |
** |
|
Taxes |
541 |
0.2 |
|
Misc. G & A |
211 |
** |
|
|
|
|
|
Total G & A Expenses |
57,445 |
21.9 |
| MARKETING EXPENSES | ||
| Salaries & Cost of Employment |
25,061 |
9.5 |
|
Total Commissions Paid |
73,367 |
27.9 |
|
Credit Card Expense |
4,897 |
1.8 |
|
New Product Research |
0 |
** |
|
Conventions |
0 |
** |
|
Supplies, general |
0 |
** |
|
Sales Aids |
2,126 |
0.8 |
|
Postage Meter Rent |
162 |
** |
|
Postage |
409 |
0.1 |
|
Samples |
222 |
** |
|
Advertising |
0 |
** |
|
L.D. Telephone |
2,002 |
0.7 |
|
Pager & Cell Phone |
2,220 |
0.8 |
|
Travel & Entertainment |
223 |
** |
|
Market Research |
184 |
** |
|
Bad Debt Expense |
3,379 |
1.2 |
|
Total Marketing Expense |
114,252 |
43.5 |
|
|
|
|
|
RESEARCH & DEVELOPEMENT EXPENSES |
| |
|
Total Salaries |
0 |
** |
|
Clinical Trials |
0 |
** |
|
Misc. |
0 |
** |
|
Total R & D Expense |
0 |
** |
|
|
|
|
|
NeuroGenesis, Inc | ||
|
|
YTD Actual |
% |
|
MANUFACTURING & DELIVERY EXPENSE |
| |
|
Salaries |
0 |
** |
|
Supplies |
0 |
** |
|
Misc. Mfg Exp. |
0 |
** |
|
Freight OUT |
3,598 |
1.3 |
|
Freight IN |
1,190 |
0.4 |
|
Prior Year Exp. Paid This Yr |
0 |
** |
|
Total Mfg. and Delivery Exp. |
4,788 |
1.8 |
|
|
|
|
|
OTHER EXPENSE AND (INCOME) |
|
|
|
Interest expense (income) |
17,156 |
6.5 |
|
Multi-Level Marketing |
0 |
** |
|
Treatment Centers |
0 |
** |
|
Other expense (Income) |
255 |
0.1 |
|
Other Income |
0 |
** |
|
Sales discounts |
0 |
** |
|
Miscellaneous |
0 |
** |
|
|
|
|
|
Total Other Exp. and (inc) |
17,411 |
6.6 |
|
|
====== |
|
|
|
|
|
|
Net Income From Operations |
17,161 |
6.5 |
|
Assets Acquired From Law Suits |
0 |
** |
|
|
|
|
|
Extraordinary Exp From Law Suits |
0 |
** |
|
|
|
_______ |
|
NET INCOME |
17,161 |
6.5 |
|
|
|
|
|
NeuroGenesis, Inc | ||
|
ASSETS |
|
|
|
CURRENT ASSETS |
|
|
|
Cash |
|
|
|
Wells Fargo checking |
4,052 |
|
|
Bank of America - NGI |
49,038 |
|
|
London 7 Schaeffer Escrow Acct |
27,093 |
|
|
Petty Cash |
0 |
|
|
Undeposited Cash from A/R |
0 |
|
|
|
|
|
|
Total Cash |
80,183 |
|
|
|
|
|
|
Accounts Receivable |
|
|
|
Accts Rec - 3N1 |
16,950 |
|
|
Accts Rec. - NHP |
4,140 |
|
|
Loans to Officers & Directors - AS |
1,800 |
|
|
AIR Shareholders |
0 |
|
|
|
|
|
|
Total Accounts Receivable |
22,890 |
|
|
|
|
|
|
Inventory |
|
|
|
beCALM'd Inventory |
14,610 |
|
|
Ultratrend Inventory |
152 |
|
|
NeuRecover - SA Inventory |
1,621 |
|
|
NeuRecover - DA Inventory |
1,005 |
|
|
NeuroSlim Inventory |
7,308 |
|
|
Inca Gold Inventory |
3,396 |
|
|
Booklets and Manuals |
497 |
|
|
Video Tapes |
0 |
|
|
|
|
|
|
Total Inventory |
28,590 |
|
|
|
|
|
|
Deposits and Prepaid's |
4,417 |
|
|
|
|
|
|
Total Current Assets |
136,080 |
|
|
|
|
|
|
FIXED ASSETS |
|
|
|
Furniture & fixtures |
4,922 |
|
|
Accum deprec-Furn & Fixt |
3,055 |
|
|
Computers |
10,278 |
|
|
Accum Depr Computers |
(4,798) |
|
|
Machinery |
1,443 |
|
|
Accum Depr of Machinery. |
(509) |
|
|
Patents |
10,410 |
|
|
Accum Depr on Patents |
(666) |
|
|
Display booths |
3,811 |
|
|
Accum Depr of Display booths |
(3,811) |
|
|
Lease Hold Improvement |
0 |
|
|
|
|
|
|
Total Fixed Assets |
18,025 |
|
|
|
======== |
|
|
Total Assets |
154,105 |
|
|
|
|
|
|
|
|
|
|
NeuroGenesis, Inc | ||
|
|
|
|
|
|
|
|
|
LIABILITIES |
|
|
|
CURRENT LIABILITIES |
|
|
|
Trade Accounts payable |
17,332 |
|
|
Loans From Officers & Directors |
1,38,717 |
|
|
Commissions Payable |
1,473 |
|
|
Deposits on Sales |
3 |
|
|
Sales tax payable |
554 |
|
|
Withheld Taxes Payable |
0 |
|
|
Bank Loans |
0 |
|
|
Total Current Liabilities |
158,079 |
|
|
|
|
|
|
EQUITY |
|
|
|
Common Shares @ $0.025 |
43,769 |
|
|
Paid in capital |
1,780,938 |
|
|
Long Term Debt |
155,959 |
|
|
Retained earnings |
(1,984,640) |
|
|
|
|
|
|
Total Equity |
(3,974) |
|
|
|
|
|
|
TOTAL LIABILITIES |
154,105 |
|
|
|